StonvexLoading…
StonvexCore line items from EPRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $162.49M | $158.80M | $561.22M | $411.35M | $266.42M |
Operating Income | Not available | $89.65M | $359.92M | $261.17M | $167.43M |
Net Income | Not available | $59.79M | $253.01M | $184.94M | $119.32M |
EPS (Diluted) | $0.34 | $0.28 | $1.28 | $0.94 | $0.61 |
Total Assets | Not available | $7.15B | $6.86B | $6.61B | $6.29B |
Total Liabilities | Not available | $2.76B | $2.66B | $2.77B | $2.45B |
Cash & Equivalents | Not available | $15.18M | $60.18M | $23.84M | $20.78M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 216.25M | 209.70M | 198.14M | 198.14M |